Our Team

Board of Directors

LAUREN LEIMAN

Executive Director, BLOODPAC Consortium

President & Board Member

PHILLIP G. FEBBO, MD

Chief Scientific Officer & Chief Medical Officer, Veracyte

Treasurer & Board Member

PETER KUHN, PH.D.Professor, University of Southern California

PETER KUHN, PhD

Professor, University of Southern California

Board Member

LUCA QUAGLIATA, PhD

Vice President & Corporate Head, Medical Affairs Office, Products & Technology Sector, Thermo Fisher Scientific

Board Member

ROBERT LOBERG, PhD

Vice President, Life Cycle Leader - Oncology & Genetics, Roche

Secretary & Board Member

JAKE VINSONChief Executive Officer, Prostate Cancer Clinical Trials Consortium

JAKE VINSON

Chief Executive Officer, Prostate Cancer Clinical Trials Consortium

Board Member

Scientific Advisory Committee

JIM GODSEY, PhD

BLOODPAC

ROBERT L. GROSSMAN, PhD

Professor, University of Chicago CTDS & Founder/Director, Open Commons Consortium

JERRY LEE, PhD

Professor and Director, Precision Health Network, Arizona State University

CAROLYN COMPTON, MD, PhD

Professor, Arizona State University

Scientific Co-Chair Committee

JONATHAN BADEN

Executive Director, Head of Precision Medicine, Bristol Myers Squibb

KELLI BRAMLETT

Executive Director, Molecular Oncology, Quest Diagnostics
Committee Chair

DARYA CHUDOVA, PH.D.Senior Vice President, Technology, Guardant Health

DARYA CHUDOVA, PhD

Chief Technology Officer, Guardant Health

JENNIFER DICKEY, PhD

Head of Regulatory and Quality, Labcorp

ELIZABETH MANSFIELD, PhD

Vice President, Regulatory Policy, Foundation Medicine

TRACI PAWLOWSKI, PhD

Vice President of R&D, NeoGenomics

ANGELA SILVESTRO

Director, Companion Diagnostics, GSK

JOHN SIMMONS

Global Vice President, Biopharma & Oncology Partnerships, Natera

BLOODPAC Team

BRIAN MINIE

Director of Data Science, BLOODPAC

CHEYENNE JANKIEWICZ

Program Manager, BLOODPAC

DORYS LOPEZ, PhD

Head of Scientific Communications, BLOODPAC

GINGER RIESSEN, CPA

Accountant, BLOODPAC